National Guideline Clearinghouse | Aromatase inhibitors as adjuvant therapy in postmenopausal women with early-stage hormone receptor positive breast cancer.
March 18, 2013
Guideline Title
Aromatase inhibitors as adjuvant therapy in postmenopausal women with early-stage hormone receptor positive breast cancer.
Bibliographic Source(s)
Alberta Provincial Breast Tumour Team. Aromatase inhibitors as adjuvant therapy in postmenopausal women with early-stage hormone receptor positive breast cancer. Edmonton (Alberta): Alberta Health Services, Cancer Care; 2011 Jun. 10 p. (Clinical practice guideline; no. BR-003). [42 references] |
Guideline Status
This is the current release of the guideline.
No hay comentarios:
Publicar un comentario